Managing varicella zoster virus contact and infection in patients on anti-rheumatic therapy
| Autor: | Matthew Cates, Andrew Ustianowski, Sophie Gillet, Matthew Donati, James Galloway |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Pediatrics
Herpesvirus 3 Human viruses Acyclovir Varicella medicine.disease_cause Antibodies Viral VZV Serology Zoster Chickenpox 0302 clinical medicine Risk Factors Contact Pharmacology (medical) 030212 general & internal medicine virus diseases Immunosuppressed Varicella zoster virus Antirheumatic Agents Child Preschool Varicella zoster immunoglobulin Female Infection Shingles Adult medicine.medical_specialty Antiviral Agents Virus VZIG 03 medical and health sciences Immunocompromised Host Rheumatology Internal medicine Rheumatic Diseases medicine Humans Antiviral 030203 arthritis & rheumatology business.industry Public health Varicella zoster immune globulin medicine.disease Virology Varicella Zoster Virus Infection business Vaccine |
| Zdroj: | Cates, M, Donati, M, Gillet, S, Ustianowski, A & Galloway, J 2018, ' Managing varicella zoster virus contact and infection in patients on anti-rheumatic therapy ', Rheumatology (United Kingdom), vol. 57, no. 4, pp. 596-605 . https://doi.org/10.1093/rheumatology/kex189 |
| ISSN: | 1462-0332 |
| DOI: | 10.1093/rheumatology/kex189 |
| Popis: | Chickenpox and shingles can be more severe and occasionally life threatening in immunosuppressed patients. As such, some groups warrant a more detailed history, serological testing and consideration of prophylaxis following contact with the virus. Active disease may also require more aggressive treatment with antivirals. Guidance for the use of varicella zoster immunoglobulin has recently been updated by Public Health England with important implications for rheumatology patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|